Comparative levels of macrophage migration inhibitory factor, procalcitonin, osteoprotegerin, interleukin-8, hs-C reactive protein, d-dimer in febrile neutropenia, newly diagnosed cancer patients, and infectious fever
Autor: | Halil Kirbiyik, Meltem Avci, Giray Bozkaya, Tolgay Isikyakar, Ismail Sari, Levent Kebapcilar, Arif Yuksel, Oktay Bilgir, Ferda Bilgir, Mehmet Calan |
---|---|
Rok vydání: | 2012 |
Předmět: |
Calcitonin
Male medicine.medical_specialty Neutropenia Fever Calcitonin Gene-Related Peptide Antineoplastic Agents Infections Malignancy Procalcitonin Fibrin Fibrinogen Degradation Products Osteoprotegerin Neoplasms Internal medicine medicine Humans Prospective Studies Protein Precursors Macrophage Migration-Inhibitory Factors Hematology biology business.industry Interleukin-8 C-reactive protein medicine.disease Intramolecular Oxidoreductases C-Reactive Protein Immunology biology.protein Female Macrophage migration inhibitory factor business Febrile neutropenia |
Zdroj: | Transfusion and Apheresis Science. 46:19-24 |
ISSN: | 1473-0502 |
DOI: | 10.1016/j.transci.2011.10.019 |
Popis: | Background The purpose of this study is to determine the levels of procalcitonin (PCT), IL-8 (interleukin-8), MIF (macrophage migration inhibitory factor), osteoprotegerin (OPG), hs-CRP and d -dimer during fever above 38.3 °C due to various causes. Material and methods Blood samples taken from a total of consecutive 65 hospitalized patients during fever were prospectively tested for hsCRP, PCT, IL-8, OPG, MIF and d -dimer. Of these patients, there were 26 patients presenting with chemotherapy-induced neutropenia who had no infectious agents found; 23 patients, who had a malignancy with a febrile episode which was neither a microbiologically documented infection nor a chemotherapy-induced neutropenia, and 16 patients who did not have a malignancy and were considered to have a clinically and microbiologically documented infection. Results IL-8 and d -dimer levels were higher in patients with febrile neutropenia than in the other two groups. Although MIF and OPG were higher in patients with newly diagnosed cancers, there were no differences among the three groups regarding PCT and hs-CRP values. Conclusion High serum IL-8 and d -dimer levels can be useful markers to identify hospitalized chemotherapy-induced neutropenia patients. MIF and OPG were found to be higher in patients with newly diagnosed cancer. |
Databáze: | OpenAIRE |
Externí odkaz: |